Johnson LB - Search Results

1

Excellence in Antibiotic Stewardship: A mixed methods study comparing High, Medium, and Low Performing Hospitals.

Vaughn VM, Krein SL, Hersh A, Buckel WR, White AT, Horowitz J, Patel PK, Gandhi TN, Petty LA, Spivak ES, Bernstein SJ, Malani AM, Johnson LB, Neetz RA, Flanders SA, Galyean P, Kimball E, Bloomquist K, Zickmund T, Zickmund SL, Szymczak JE. Vaughn VM, et al. Among authors: johnson lb. Clin Infect Dis. 2023 Dec 6:ciad743. doi: 10.1093/cid/ciad743. Online ahead of print. Clin Infect Dis. 2023. PMID: 38059532

2

Infectious diseases subspecialty: declining demand challenges and opportunities.

Chandrasekar P, Havlichek D, Johnson LB. Chandrasekar P, et al. Among authors: johnson lb. Clin Infect Dis. 2014 Dec 1;59(11):1593-8. doi: 10.1093/cid/ciu656. Epub 2014 Aug 22. Clin Infect Dis. 2014. PMID: 25148890 Free PMC article.

3

Molecular analysis of coagulase-negative Staphylococcus isolates from blood cultures: prevalence of genotypic variation and polyclonal bacteremia.

Sharma M, Riederer K, Johnson LB, Khatib R. Sharma M, et al. Among authors: johnson lb. Clin Infect Dis. 2001 Oct 15;33(8):1317-23. doi: 10.1086/322673. Epub 2001 Sep 17. Clin Infect Dis. 2001. PMID: 11565071

4

Voriconazole: a new triazole antifungal agent.

Johnson LB, Kauffman CA. Johnson LB, et al. Clin Infect Dis. 2003 Mar 1;36(5):630-7. doi: 10.1086/367933. Epub 2003 Feb 10. Clin Infect Dis. 2003. PMID: 12594645 Review.

5

Frequency of reduced vancomycin susceptibility and heterogeneous subpopulation in persistent or recurrent methicillin-resistant Staphylococcus aureus bacteremia.

Khosrovaneh A, Riederer K, Saeed S, Tabriz MS, Shah AR, Hanna MM, Sharma M, Johnson LB, Fakih MG, Khatib R. Khosrovaneh A, et al. Among authors: johnson lb. Clin Infect Dis. 2004 May 1;38(9):1328-30. doi: 10.1086/383036. Epub 2004 Apr 14. Clin Infect Dis. 2004. PMID: 15127350

6

Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.

Khatib R, Saeed S, Sharma M, Riederer K, Fakih MG, Johnson LB. Khatib R, et al. Among authors: johnson lb. Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):181-5. doi: 10.1007/s10096-006-0096-0. Eur J Clin Microbiol Infect Dis. 2006. PMID: 16505987

7

Community-associated methicillin-resistant Staphylococcus aureus causing chronic pneumonia.

Enayet I, Nazeri A, Johnson LB, Riederer K, Pawlak J, Saravolatz LD. Enayet I, et al. Among authors: johnson lb. Clin Infect Dis. 2006 Apr 1;42(7):e57-60. doi: 10.1086/501125. Epub 2006 Feb 28. Clin Infect Dis. 2006. PMID: 16511747

8

Etravirine, a next-generation nonnucleoside reverse-transcriptase inhibitor.

Johnson LB, Saravolatz LD. Johnson LB, et al. Clin Infect Dis. 2009 Apr 15;48(8):1123-8. doi: 10.1086/597469. Clin Infect Dis. 2009. PMID: 19275497 Review.

9

Telavancin: a novel lipoglycopeptide.

Saravolatz LD, Stein GE, Johnson LB. Saravolatz LD, et al. Among authors: johnson lb. Clin Infect Dis. 2009 Dec 15;49(12):1908-14. doi: 10.1086/648438. Clin Infect Dis. 2009. PMID: 19911938 Review.

10

Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus.

Saravolatz LD, Stein GE, Johnson LB. Saravolatz LD, et al. Among authors: johnson lb. Clin Infect Dis. 2011 May;52(9):1156-63. doi: 10.1093/cid/cir147. Clin Infect Dis. 2011. PMID: 21467022 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page